Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 32, Pages 19471-19477
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-06-23
DOI
10.1074/jbc.r115.654764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis, Pharmacological Characterization, and Structure–Activity Relationship Studies of Small Molecular Agonists for the Orphan GPR88 Receptor
- (2014) Chunyang Jin et al. ACS Chemical Neuroscience
- A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
- (2014) R. J. Gralla et al. ANNALS OF ONCOLOGY
- Molecular control of δ-opioid receptor signalling
- (2014) Gustavo Fenalti et al. NATURE
- Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial
- (2014) H. Kaufmann et al. NEUROLOGY
- Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
- (2014) William D. Chey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biased ligands at G-protein-coupled receptors: promise and progress
- (2014) Jonathan D. Violin et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled Receptor
- (2013) Dahlia R. Weiss et al. ACS Chemical Biology
- Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands
- (2013) Evangelia Kotsikorou et al. BIOCHEMISTRY
- Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists
- (2013) Eyal Vardy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs
- (2013) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure of the human smoothened receptor bound to an antitumour agent
- (2013) Chong Wang et al. NATURE
- A pharmacological organization of G protein–coupled receptors
- (2013) Henry Lin et al. NATURE METHODS
- Emerging paradigms in GPCR allostery: implications for drug discovery
- (2013) Denise Wootten et al. NATURE REVIEWS DRUG DISCOVERY
- Structural Basis for Molecular Recognition at Serotonin Receptors
- (2013) C. Wang et al. SCIENCE
- Structural Features for Functional Selectivity at Serotonin Receptors
- (2013) D. Wacker et al. SCIENCE
- In Silico Molecular Comparisons of C. elegans and Mammalian Pharmacology Identify Distinct Targets That Regulate Feeding
- (2013) George A. Lemieux et al. PLOS BIOLOGY
- Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors
- (2012) Xingyu Lin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of the human κ-opioid receptor in complex with JDTic
- (2012) Huixian Wu et al. NATURE
- Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
- (2012) Aaron A. Thompson et al. NATURE
- Large-scale prediction and testing of drug activity on side-effect targets
- (2012) Eugen Lounkine et al. NATURE
- Automated design of ligands to polypharmacological profiles
- (2012) Jérémy Besnard et al. NATURE
- TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
- (2012) Asuka Inoue et al. NATURE METHODS
- Identifying mechanism-of-action targets for drugs and probes
- (2012) E. Gregori-Puigjane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
- (2011) John A. Allen et al. Annual Review of Pharmacology and Toxicology
- Identification of the GPR55 Agonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands
- (2011) Evangelia Kotsikorou et al. BIOCHEMISTRY
- Too many roads not taken
- (2011) Aled M. Edwards et al. NATURE
- Chemical informatics and target identification in a zebrafish phenotypic screen
- (2011) Christian Laggner et al. Nature Chemical Biology
- Ligand discovery from a dopamine D3 receptor homology model and crystal structure
- (2011) Jens Carlsson et al. Nature Chemical Biology
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β-arrestin-2
- (2010) Laura Jenkins et al. BRITISH JOURNAL OF PHARMACOLOGY
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
- (2010) Wolfgang Glaesner et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
- (2010) Christopher D. Cox et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and -Arrestin2 with Antinociceptive Activity
- (2010) P. Zhao et al. MOLECULAR PHARMACOLOGY
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
- (2009) M. A. Bush et al. DIABETES OBESITY & METABOLISM
- Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
- (2009) Richard C Becker et al. LANCET
- Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment
- (2009) X.-P. Huang et al. MOLECULAR PHARMACOLOGY
- Predicting new molecular targets for known drugs
- (2009) Michael J. Keiser et al. NATURE
- PubChem: a public information system for analyzing bioactivities of small molecules
- (2009) Y. Wang et al. NUCLEIC ACIDS RESEARCH
- Massively Parallel Screening of the Receptorome
- (2008) Niels Jensen et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes
- (2008) Jessica E. Matthews et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
- (2008) W. J. Thomsen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials
- (2008) Shantha MW Rajaratnam et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now